Translational Drug Development (TD2) Press Releases - EIN Presswire

Published on February 11, 2025 - 11:00 GMT

TD2 Oncology Announces Bill Donovan as SVP, Strategic Solutions to Advance Resourcing and FSP Capabilities

SCOTTSDALE, AZ, UNITED STATES, February 11, 2025 /⁨EINPresswire.com⁩/ -- TD2 Oncology, a leading contract research organization (CRO), announces the addition of Bill Donovan as Senior Vice President, Strategic Solutions. Donovan has joined TD2 Oncology to …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on September 4, 2024 - 12:00 GMT

Translational Drug Development (TD2) Expands Clinical Trial Services into Europe

SCOTTSDALE, ARIZONA, UNITED STATES, September 4, 2024 /⁨EINPresswire.com⁩/ -- Translational Drug Development (TD2), a leading provider of comprehensive preclinical drug development, translational and clinical trial services, announces the formation of a …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on April 3, 2024 - 12:00 GMT

TD2 to Present Precision Preclinical Applications for Glioblastoma and Non-Small Cell Lung Cancer at AACR Annual Meeting

Three Poster Presentations Highlight Novel Data SCOTTSDALE, ARIZONA, UNITED STATES, April 3, 2024 /⁨EINPresswire.com⁩/ -- Translational Drug Development (TD2), a precision oncology contract research organization (CRO), announces the presentation of their …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...

Published on February 1, 2024 - 13:00 GMT

TD2 Expands Preclinical and Clinical Services by Acquiring Flow Contract Site Laboratory (FCSL)

Strengthening its Translational Oncology Ecosystem SCOTTSDALE, ARIZONA, USA, February 1, 2024 /⁨EINPresswire.com⁩/ -- Translational Drug Development (TD2), a leading provider of comprehensive preclinical drug development, translational and clinical trial …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on December 5, 2023 - 13:00 GMT

TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting

SCOTTSDALE, ARIZONA, USA, December 5, 2023 /⁨EINPresswire.com⁩/ -- Translational Drug Development (TD2), a precision oncology contract research organization (CRO), announces the presentation of preclinical results of RR-1752, a targeted inhibitor of ROCK/ …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...

Published on May 17, 2023 - 13:00 GMT

Tara Franks, Chief Operating Officer of TD2, recognized as a 2023 Phoenix Titan 100

SCOTTSDALE, ARIZONA, UNITED STATES, May 17, 2023 /⁨EINPresswire.com⁩/ -- Titan CEO and headline sponsor Wipfli LLP are pleased to announce Tara Franks, Chief Operating Officer of Translational Drug Development (TD2), as a 2023 Phoenix Titan 100. The Titan …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on April 11, 2023 - 13:00 GMT

TD2 to Highlight the Development of a Novel Metabolomic Cancer Model at the AACR Annual Meeting 2023

"Antitumor and Metabolomic Evaluation of Immune Checkpoint Inhibition in Diet-Induced Obese Mice," will be presented under poster number LB343 on April 19. SCOTTSDALE, ARIZONA, UNITED STATES, April 11, 2023 /⁨EINPresswire.com⁩/ -- Translational …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on October 5, 2022 - 10:00 GMT

TD2 Announces Dr. Alan Miller as New Chief Medical Officer

The respected Medical Oncology leader brings extensive experience as TD2 continues its strategic growth. SCOTTSDALE, ARIZONA, UNITED STATES, October 5, 2022 /⁨EINPresswire.com⁩/ -- Translational Drug Development (TD2), a precision oncology contract …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on April 5, 2022 - 13:00 GMT

TD2 to Highlight Preclinical Progress of Two Novel HDAC Inhibitors at AACR Annual Meeting

SCOTTSDALE, ARIZONA, UNITED STATES, April 5, 2022 /⁨EINPresswire.com⁩/ -- Translational Drug Development (TD2), a precision oncology contract research organization (CRO), announces the presentation of the preclinical results of two novel, targeted …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2022 - 14:40 GMT

Effects of a Metabolic Nutritional Intervention Combined with Chemotherapy for Advanced Pancreatic Cancer

Poster Presented at ASCO GI Annual Meeting SCOTTSDALE, ARIZONA, UNITED STATES, February 2, 2022 /⁨EINPresswire.com⁩/ -- Translational Drug Development (TD2), a precision oncology contract research organization (CRO), announces the presentation of their …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...